Multidrug-Resistant and Carbapenemase-Producing Enterobacteriaceae in Addis Ababa, Ethiopia

被引:9
作者
Tekele, Saba Gebremichael [1 ]
Teklu, Dejenie Shiferaw [2 ]
Legese, Melese Hailu [3 ]
Weldehana, Daniel Gebretsadik [1 ]
Belete, Melaku Ashagrie [1 ]
Tullu, Kassu Desta [3 ]
Birru, Samuel Kinde [3 ]
机构
[1] Wollo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Dessie, Ethiopia
[2] Ethiopian Publ Hlth Inst, Dept Bacteriol & Mycol, Addis Ababa, Ethiopia
[3] Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia
关键词
SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; HIGH PREVALENCE; HOSPITALIZED CHILDREN; ESCHERICHIA-COLI; UROPATHOGENS; KATHMANDU; SPREAD; KPC-2;
D O I
10.1155/2021/9999638
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. The emergence and spread of multi-drug resistant (MDR) bacteria have become a public health problem in recent years. For the last many years, carbapenem antibiotics have been used successfully to treat infections caused by MDR Enterobacteriaceae. However, recently, Enterobacteriaceae producing carbapenemases have emerged, which confer broad resistance to most beta-lactam antibiotics including carbapenems. Therefore, this study is aimed at determining the magnitude of MDR and carbapenemase-producing Enterobacteriaceae (CPE) isolated from various clinical specimens in Addis Ababa, Ethiopia. Methods. A cross-sectional study was conducted from January to April 2018. A total of 312 Enterobacteriaceae isolates were identified from various clinical specimens. The Phoenix automated system (BD Phoenix100) was used for bacterial identification and antimicrobial susceptibility testing. Potential carbapenemase producers were confirmed by the modified carbapenem inactivation test, and KPC, MBL, and OXA-48 were phenotypically characterized by the disk diffusion method. The data obtained were entered and analyzed using SPSS version 20 software. Descriptive statistics, chi square, bivariate and multivariable logistic regression analyses were performed. P value <= 0.05 with corresponding 95% confidence interval was considered for statistical significance. Results. A total of 312 Enterobacteriaceae were recovered. Of these isolates, 68.6% were MDR and 2.6% were CPE with different classes including OXA-48 1.6% (5/312), MBL 0.6% (2/312), and KPC and OXA-48 0.3% (1/312). The predominant bacterial isolates were E. coli 72.4% (226/312) followed by K. pneumoniae 13.8% (43/312). The antibiotic resistance rates of CPE isolates were significantly higher than other MDRE including ampicillin (100% versus 77.6%), cefoxitin (75% versus 20.6%), and piperacillin/tazobactam (50% versus 13.1%). Conclusion. In this study, a relatively higher prevalence of MDR was observed, and the highest resistance was recorded against ampicillin, amoxicillin with clavulanic acid, and sulfamethoxazole-trimethoprim. Detection of CPE is important for implementing appropriate antimicrobial therapy and in controlling the spread of the infection. Furthermore, continuous screening and investigations, including genotypic characterization of CPE, are required for the prevention and control of the spread of antimicrobial-resistant pathogens.
引用
收藏
页数:10
相关论文
共 49 条
[1]  
Abera B, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/JOURNAL.PONE.0166519
[2]   Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria [J].
Akova, M. ;
Daikos, G. L. ;
Tzouvelekis, L. ;
Carmeli, Y. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (05) :439-448
[3]  
Amjad A, 2011, IRAN J MICROBIOL, V3, P189
[4]  
[Anonymous], ROSCO KPC MBL OXA 48
[5]   Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study [J].
Aqel, Amin A. ;
Giakkoupi, Panagiota ;
Alzoubi, Hamed ;
Masalha, Ibrahim ;
Ellington, Matthew J. ;
Vatopoulos, Alkiviadis .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (02) :150-155
[6]   High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal [J].
Baral P. ;
Neupane S. ;
Marasini B. ;
Ghimire K. ;
Lekhak B. ;
Shrestha B. .
BMC Research Notes, 5 (1)
[7]  
Bedeni B., 2014, LAB DETECT CLIN SIGN, V3
[8]  
Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P165
[9]  
Centers for Disease Control and Prevention. US Department of Health and Human Services, 2013, ANTIBIOTIC RESISTANC
[10]  
CLSI, 2016, CLSI